Michele N. Pham, None; Mauro T. Leite, None; Christopher Bowd, Pfizer Inc. (F); Christopher A. Girkin, Alcon Laboratories Inc. (C), Allergan Inc. (C), Carl Zeiss Meditec Inc. (R), Heidelberg Engineering Inc. (R), Merck Inc. (R), Optive Inc. (R), Pfizer Inc. (C), Topcon Medical Systems Inc. (R); Jeffrey M. Liebmann, Alcon Laboratories Inc. (C), Allergan Inc. (C), Carl Zeiss Meditec Inc. (F), Dyopsis Corp. (C, F), Heidelberg Engineering (F), Optovue Inc. (C, F), Pfizer Inc. (C), Topcon Medical Systems Inc. (F, C); Felipe A. Medeiros, Alcon Laboratories (F, R), Alcon Laboratories Inc. (C), Allergan Inc (R), Allergan Inc. (C), Carl Zeiss Meditec (F), Carl Zeiss Meditec Inc (R), Merck Inc. (F), Pfizer Inc (R), Pfizer Inc. (F, C), Reichert Inc (R); Pamela A. Sample, Carl Zeiss Meditec Inc. (F), Haag-Streit (F); Robert N. Weinreb, Alcon Laboratories Inc. (C), Allergan Inc. (C), Carl Zeiss Meditec Inc. (F, C), Heidelberg Engineering GmbH (F), Merck (C), Novartis (F), Optovue Inc. (F, C), Pfizer (C), Topcon Medical Systems (F); Linda M. Zangwill, Carl Zeiss Meditec Inc. (F), Heidelberg Engineering (R), Heidelberg Engineering GmbH (F), Optovue Inc. (F), Topcon Medical Systems Inc. (F)